Efficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis

• Main Authors: Mai Abdelmen (Author), Nagwa Ali Sabri (Author), Sara Shahin (Author), Ashraf Ahmed Aboubakr (Author)
• 格式: 圖書
• 出版: Ain Shams University, 2020-09-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Background: The ongoing standard treatment for patients with chronic hepatitis C virus (HCV) is a mixture of direct-acting antiviral agents (DAAs). Aim of work: the aim of this study is to analyse the efficacy and safety of oral interferon-free regimen of ombitasvir, and paritaprevir with ritonavir,...